AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

High-density Flexible μECoG for Epilepsy Surgery - A Single-Arm ECT

RecruitingNAAges 3 Years - 60 YearsAllBeijing Tiantan Hospital
💬

In plain words

What the trial is, and whether it could suit you

What's the clinical value of high-density flexible microelectrocorticography (μECoG) for guiding the resection of epileptogenic zone (EZ) in epilepsy surgery?

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 3 to 60 years. 2. Diagnosis of drug-resistant epilepsy, defined as persistent seizures despite treatment with two or more appropriately selected, adequately dosed and adequately tried antiseizure medications. 3. Diagnosis of focal epilepsy after standard presurgical evaluation and considered suitable for resective epilepsy surgery. 4. Preoperative cognitive or developmental status sufficient to participate in study assessments, as judged by the investigator and assessed using age-appropriate validated instruments. For participants aged 3 to 6 years, developmental status must be within the normal range according to the Griffiths Mental Development Scales. For participants aged 6 to 16 years, cognitive function must be within the normal range according to the Wechsler Intelligence Scale for Children. For participants older than 16 years, a Mini-Mental State Examination score of 24 or higher will be required. 5. Written informed consent provided by the participant or, when applicable, by a legal guardian. Exclusion Criteria: 1. Suspected mesial temporal lobe epilepsy after multidisciplinary presurgical evaluation. 2. History of any previous neurosurgical craniotomy before epilepsy surgery. 3. Severe psychiatric, cognitive, or psychological disorder that prevents participation in the study or completion of follow-up. 4. Contraindication to surgery.
💊

What it tests

  • Using High-density Flexible microElectrocorticography for intraoperative monitoring
📍

Where

1 site
Beijing Tiantan Hospital
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy